loading page

Toxic epidermal necrosis following Sinopharm COVID-19 vaccine (BBIBP-CorV): A case report and literature review
  • Safoura Shakoei,
  • Alireza hadizadeh
Safoura Shakoei
Tehran University of Medical Sciences

Corresponding Author:dr.shakoei@gmail.com

Author Profile
Alireza hadizadeh
Tehran University of Medical Sciences
Author Profile

Abstract

This study reports a patient developing TEN after the first dose of (BBIBP-CorV). He developed numerous purpuric and dusky patches with flaccid bullae and areas of epidermal detachment covered more than 30% of the body area within 6 days. After treatment with dexamethasone and cyclosporin, he recovered within 14 days.
31 May 2022Submitted to Clinical Case Reports
02 Jun 2022Submission Checks Completed
02 Jun 2022Assigned to Editor
25 Jun 2022Reviewer(s) Assigned
10 Aug 2022Review(s) Completed, Editorial Evaluation Pending
27 Aug 2022Editorial Decision: Revise Minor
15 Oct 20221st Revision Received
15 Oct 2022Submission Checks Completed
15 Oct 2022Assigned to Editor
15 Oct 2022Review(s) Completed, Editorial Evaluation Pending
26 Nov 2022Editorial Decision: Accept
Dec 2022Published in Clinical Case Reports volume 10 issue 12. 10.1002/ccr3.6726